default author photo

Puyuan Xing

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology

Beijing

China

SCHOLARLY PAPERS

2

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of LY01610 (an Irinotecan Hydrochloride Liposome Injection) as a Second-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC)

Number of pages: 49 Posted: 19 Mar 2024
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Government of the People's Republic of China - Second People's Hospital of Yibin, Bengbu Medical College - Department of Medical Oncology, Xuzhou Central Hospital - Department of Medical Oncology, Bengbu Medical College - Department of Medical Oncology, Guangdong Pharmaceutical University - Department of Medical Oncology, Shantou University - Medical College, Guangzhou Medical University, Xingtai People's Hospital, Chongqing Medical University, University of Science and Technology of China (USTC) - Department of Thoracic Cancer Chemotherapy, University of Science and Technology of China (USTC), Chongqing University, Chongqing University, Chongqing University, Luye Life Sciences Group, Nanjing Luye Pharmaceutical Co Ltd and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs
Downloads 67 (916,100)

Abstract:

Loading...

irinotecan liposome, LY01610, relapsed small cell lung cancer

2.

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer

Number of pages: 42 Posted: 01 Jun 2021
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences - State Key Lab of Molecular Oncology, Geneplus-Beijing Co. Ltd. - Medical Center, Geneplus-Beijing Co. Ltd. - Medical Center, Capital Medical University - Department of Respiratory and Critical Care Medicine, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Geneplus-Beijing Co. Ltd., Geneplus-Beijing Institute, Geneplus-Beijing Institute, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs
Downloads 63 (933,592)

Abstract:

Loading...

Small-cell lung cancer; Molecular tumor burden index; Circulating tumor DNA sequencing; Progression-free survival; Predictive classifiers